Cryopreservation of supernumerary high quality embryos predicts favorable outcomes for patients undergoing repeated cycles of in vitro fertilization

被引:28
作者
Wang, Jeff G. [1 ]
Douglas, Nataki C. [1 ]
Dicken, Cary [1 ]
Nakhuda, Gary S. [1 ]
Guarnaccia, Michael M. [1 ]
Sauer, Mark V. [1 ]
机构
[1] Columbia Univ, Coll Phys & Surg, Dept Obstet & Gynecol, Div Reprod Endocrinol, New York, NY USA
关键词
IVF; outcomes; repeated; frozen embryo transfer; embryo cryopreservation; pregnancy; implantation;
D O I
10.1016/j.fertnstert.2007.03.031
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To determine whether the decline in pregnancy and implantation rates in repeated fresh IVF cycles is associated with the availability of embryo cryopreservation. Design: Retrospective study. Setting: Assisted reproductive unit at an academic institution. Patient(s): Women <38 years old (1,037), undergoing nondonor fresh or frozen embryo transfer (FET) cycles between January 1, 2000 and December 31, 2005. Intervention(s): In fresh cycles, women used either pituitary desensitization or GnRH antagonists in combination with gonadotropin stimulation protocols before oocyte retrieval. In FET cycles, endometrial development was achieved by oral E-2 and vaginal P after pituitary desensitization. Embryo transfer occurred either on day 3 or on day 5. Main Outcome Measure(s): Implantation and pregnancy rates (PR). Result(s): Excluding FET cycles, implantation rates and PRs declined significantly in repeated cycles compared to the initial one. However, women with supernumerary embryos for cryopreservation appeared to produce embryos with higher implantation potential but were excluded from the analysis. When FET cycles were included, there were no significant declines in PRs for at least three repeated cycles. Conclusion(s): Embryo cryopreservation stratifies women with high quality embryos from those with low quality embryos who require repeat fresh attempts, resulting in an accelerated decline in observed PRs and implantation rates. (Fertil Steril (R) 2008;89:368-74. (c) 2008 by American Society for Reproductive Medicine.)
引用
收藏
页码:368 / 374
页数:7
相关论文
共 30 条
[1]  
Al-Inany H.G., 2006, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD001750.PUB2
[2]   Ovarian stimulation with HMG:: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin [J].
Albano, C ;
Felberbaum, RE ;
Smitz, J ;
Riethmüller-Winzen, H ;
Engel, J ;
Diedrich, K ;
Devroey, P .
HUMAN REPRODUCTION, 2000, 15 (03) :526-531
[3]  
Bahçeci M, 2005, J REPROD MED, V50, P84
[4]  
Borm G, 2000, HUM REPROD, V15, P1490
[5]  
*CDCP, 2006, 2004 ASS REPR TECHN
[6]  
*CDCP, 1997, 1995 ASS REPR TECHN
[7]  
Check M L, 2004, Clin Exp Obstet Gynecol, V31, P257
[8]   GnRH antagonist versus long GnRH agonist protocol in poor responders undergoing IVF: a randomized controlled trial [J].
Cheung, LP ;
Lam, PM ;
Lok, IH ;
Chiu, TTY ;
Yeung, SY ;
Tjer, CC ;
Haines, CJ .
HUMAN REPRODUCTION, 2005, 20 (03) :616-621
[9]   Prognostic factors in patients continuing in vitro fertilization or intracytoplasmic sperm injection treatment and dropouts [J].
De Vries, MJ ;
De Sutter, P ;
Dhont, M .
FERTILITY AND STERILITY, 1999, 72 (04) :674-678
[10]  
DEMOUZON J, 1993, FERTIL STERIL, V59, P587